|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
B
|
|
INDICATIONS:
|
|
Keratoconjunctivitis, vernal |
|
Conjunctivitis, vernal |
|
Keratitis, vernal |
| |
|
|
SIDE EFFECTS:
|
|
Chemosis |
|
conjunctival injection |
|
styes, or other signs of eye irritation not present before therapy |
|
contact dermatitis |
|
Burning or stinging of eye, mild, temporary |
|
Dryness or puffiness around the eye |
|
watering or itching of eye, increased |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
|
|
ADULT DOSE:
|
|
[Conjunctivitis, seasonal allergic]
Conjunctivitis, vernal
Keratitis, vernal or
Keratoconjunctivitis, vernal-Topical, to the conjunctiva, 1 drop four to six times a day at regular intervals. |
|
MAXIMUM ADULT DOSE:
|
|
Up to 12.8 mg.
|
|
PEDIATRIC DOSE:
|
|
[Conjunctivitis, seasonal allergic]
Conjunctivitis, vernal
Keratitis, vernal or
Keratoconjunctivitis, vernal-Children up to 4 years of age: Safety and efficacy have not been established.
Children 4 years of age and older: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
[Conjunctivitis, seasonal allergic]
Conjunctivitis, vernal
Keratitis, vernal or
Keratoconjunctivitis, vernal-Topical, to the conjunctiva, 1 drop four to six times a day at regular intervals. |
|
|
|
|
|